Traws Pharma, Inc. Stock Issued During Period, Shares, New Issues
Traws Pharma, Inc. (TRAW) had Stock Issued During Period, Shares, New Issues of 5.00 million shares as of 2021-09-28, per its 10-K filed 2023-03-30.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2023-03-30
- 2021-09-28: Stock Issued During Period, Shares, New Issues 5.00M shares.
- 2021-02-16: Stock Issued During Period, Shares, New Issues 1.92M shares; Stock Issued During Period, Shares, New Issues as first filed 28.75M shares.
- 2021-01-11: Stock Issued During Period, Shares, New Issues 1.30M shares; Stock Issued During Period, Shares, New Issues as first filed 19.55M shares.
- 2020-01-31: Stock Issued During Period, Shares, New Issues 1 month 27.66M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues as first filed | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|---|
| 2021-09-28 | 5.00M shares 10-K · filed 2023-03-30 | ||
| 2021-02-16 | 1.92M shares 10-K · filed 2023-03-30 | 28.75M shares 10-Q · filed 2021-05-17 | |
| 2021-01-11 | 1.30M shares 10-K · filed 2023-03-30 | 19.55M shares 10-Q · filed 2021-05-17 | |
| 2020-01-31 | 27.66M shares 10-K · filed 2020-03-27 | ||
| 2020-01-03 | 1.84M shares 10-K · filed 2022-03-21 | 27.66M shares 10-Q · filed 2020-05-15 | |
| 2019-12-19 | 13.88M shares 10-K · filed 2021-03-18 | ||
| 2019-12-10 | 14.33M shares 10-K · filed 2021-03-18 | ||
| 2019-11-30 | 30.25M shares 10-K · filed 2021-03-18 | ||
| 2019-11-21 | 30.25M shares 10-K · filed 2021-03-18 | ||
| 2019-09-25 | 2.20M shares 10-K · filed 2021-03-18 | ||
| 2018-05-01 | 3.69M shares 10-K · filed 2020-03-27 | ||
| 2018-02-12 | 467.00K shares 10-K · filed 2020-03-27 | ||
| 2017-11-14 | 61.33K shares 10-Q · filed 2019-11-12 | ||
| 2017-05-17 | 24.24K shares 10-Q · filed 2019-11-12 | ||
| 2017-04-26 | 165.08K shares 10-Q · filed 2019-11-12 | ||
| 2016-07-29 | 16.00K shares 10-Q · filed 2021-11-15 | 239.99K shares 10-Q · filed 2019-11-12 | |
| 2016-01-05 | 861.00 shares 10-Q · filed 2021-11-15 | 12.91K shares 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |